A case report shows early benralizumab improves peripheral neuropathy in a woman, indicating potential benefits for corticosteroid withdrawal.
A woman in her 40s with bronchial asthma presented with a 3-week history of limb numbness. Examinations revealed bilateral wheezing and neurological deficits involving both the lower limbs and the right upper limb. Laboratory tests revealed marked eosinophilia (14,300/μL), leading to a diagnosis of eosinophilic granulomatosis with polyangiitis. The initial treatment with prednisolone and intravenous immunoglobulin improved the systemic symptoms; however, peripheral neuropathy persisted. The early initiation of benralizumab therapy resulted in a marked neurological improvement, thus allowing the tapering and discontinuation of prednisolone. At this time, the patient remains relapse-free, suggesting that early benralizumab administration may improve peripheral neuropathy and facilitate corticosteroid withdrawal.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: